Q/C Technologies, Inc. (NasdaqCM: QCLS)
Health Care · Pharmaceuticals · US
$0.58
-7.48% today · -83.8% 1Y
Q/C Technologies, Inc. (NasdaqCM: QCLS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.16M and employs 3 people.
Over the last twelve months the share price has lost 83.8%, trading between 0.42 and 8.17.
Tweenvest scores Q/C Technologies, Inc. across four factors: quality 36/100, value 35/100. Its strongest factor is quality.
QCLS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.16M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.17
- Dividend yield
- —
- Beta (5Y)
- 2.33
- 52-week high
- $8.17
- 52-week low
- $0.42
- Avg volume (3M)
- —
- Shares outstanding
- 8.19M
- Employees
- 3
- Next earnings
- —
About Q/C Technologies, Inc.
Q/C Technologies, Inc. focuses its efforts on pioneering advanced quantum-class photonic computing and developing robust blockchain infrastructure. The company possesses the sole worldwide rights to LightSolver's revolutionary Light-speed Laser Processing Unit (LPU). This innovative optical and laser-driven computing system is engineered specifically for applications within the cryptocurrency sector, offering a substantial energy efficiency improvement of up to 90% while simultaneously outperforming both conventional GPUs and even quantum computing systems.
- ISIN
- US62856X3008
- Founded
- 2014
- Listed since
- Jan 23, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lexaria Bioscience Corp.NasdaqCM: LEXX | $5.49M | $3.32 | 0.00% |
| Glow Lifetech Corp.CNSX: GLOW | $5.39M | CA$0.04 | -11.11% |
| Pulmatrix, Inc.NasdaqCM: PULM | $5.33M | $1.43 | -2.40% |
| Christina Lake Cannabis Corp.CNSX: CLC | $5.22M | CA$0.03 | +20.00% |
| Mangalam Drugs & Organics LimitedBSE: 532637 | $5.15M | Rs31.50 | +8.62% |
| Blue Wave Water Capital LtdTASE: BLWV-M | $5.13M | ₪2.97 | +26.35% |
| Processa Pharmaceuticals, Inc.NasdaqCM: PCSA | $5.09M | $1.83 | +20.07% |
| Percheron Therapeutics LimitedASX: PER | $5.07M | AU$0.00 | -11.11% |
Figures last refreshed Oct 11, 2026.